Novel technology platform for infectious diseases
Vir Biotechnology, based in San Francisco, focuses on finding innovative solutions to unmet needs in infectious disease.
-
Domain
-
Investment typeDirect equity
-
StatusActive
-
Initial investmentSeries A-1
-
Partnered in2016
-
Investment leadRyan Kreitzer
-
HeadquartersUSA
-
Program strategyHIV
More about our work
Our focus
Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.
Investment approach
Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.
Our team
We bring depth of experience to every investment, with a proven track record across sectors and scale.